Aimmune Therapeutics, the company behind the AR101 oral immunotherapy (OIT) treatment for peanut allergy, announced on Dec. 20, 2018 that… Read more »
Tag: clinical trials
Difference Maker: A Teen Who Got Involved in Food Allergy Research
Meet the teenager impacting research as an intern and study participant.
Celiac Disease Treatment Licensed and Headed to Late-Stage Clinical Trials
The drug, based on the compound larazotide acetate, has received FDA “fast track” designation.
OIT’s Effects Endure at Low Doses: Stanford Study
In a long-term follow-up study, oral immunotherapy (OIT) patients who were treated for up to five food allergies were able to maintain a high level of desensitization to their allergens, even those taking very low “doses” of their allergens.